Treatment of Macular Degeneration Seniors and others at risk for AMD should be aware and relieved that we have made significant advances in treatment using retina injections such as Lucentis® (Ranibizumab), Eylea® (Aflibercept), VABYSMO® (Faricimab) Retina Injections for treatment of Wet AMD, and SYFOVRE™ & IZERVAY™ Injections for treatment of Geographic Atrophy (GA), an advanced form of Dry AMD. These injections can often slow the progression of the disease preserve vision that was thought to be lost for many patients. Therefore, in most cases, AMD is not an automatic path to blindness or even vision loss among seniors-if you are aware of risk factors and proactive in getting regular eye exams. Early detection and treatment are the key to preventing vision loss from AMD.